ATE499946T1 - Verwendung von hgf für die behandlung von ischämischen erkrankungen der extremitäten - Google Patents

Verwendung von hgf für die behandlung von ischämischen erkrankungen der extremitäten

Info

Publication number
ATE499946T1
ATE499946T1 AT99935079T AT99935079T ATE499946T1 AT E499946 T1 ATE499946 T1 AT E499946T1 AT 99935079 T AT99935079 T AT 99935079T AT 99935079 T AT99935079 T AT 99935079T AT E499946 T1 ATE499946 T1 AT E499946T1
Authority
AT
Austria
Prior art keywords
hgf
extremities
treatment
ischemic disease
administered
Prior art date
Application number
AT99935079T
Other languages
English (en)
Inventor
Tomokazu Nagano
Ikue Kudo
Takao Kawamura
Mutsuo Taiji
Hiroshi Noguchi
Shunsuke Tani
Hiroo Maeda
Original Assignee
Nakamura Toshikazu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nakamura Toshikazu filed Critical Nakamura Toshikazu
Application granted granted Critical
Publication of ATE499946T1 publication Critical patent/ATE499946T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT99935079T 1998-08-05 1999-08-04 Verwendung von hgf für die behandlung von ischämischen erkrankungen der extremitäten ATE499946T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22217098 1998-08-05
JP626199 1999-01-13
PCT/JP1999/004249 WO2000007615A1 (en) 1998-08-05 1999-08-04 Preparations for the administration of hepatocyte growth factor

Publications (1)

Publication Number Publication Date
ATE499946T1 true ATE499946T1 (de) 2011-03-15

Family

ID=26340360

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99935079T ATE499946T1 (de) 1998-08-05 1999-08-04 Verwendung von hgf für die behandlung von ischämischen erkrankungen der extremitäten

Country Status (10)

Country Link
US (1) US6887477B1 (de)
EP (1) EP1103269B1 (de)
KR (1) KR100761675B1 (de)
CN (1) CN1222310C (de)
AT (1) ATE499946T1 (de)
AU (1) AU5065599A (de)
CA (1) CA2339378A1 (de)
DE (1) DE69943240D1 (de)
TW (1) TWI263502B (de)
WO (1) WO2000007615A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001286221B2 (en) * 2000-09-13 2006-09-28 Chugai Seiyaku Kabushiki Kaisha Remedies for ischemic diseases
KR100562824B1 (ko) * 2002-03-20 2006-03-23 주식회사 바이로메드 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자
DE602005003211T2 (de) * 2004-03-09 2008-02-21 Tohoku Technoarch Co., Ltd., Sendai Verwendung des hepatozyten-wachstumsfaktors zur förderung der induktion der vaskulären differenzierung
WO2008102452A1 (ja) * 2007-02-22 2008-08-28 Kringle Pharma Inc. Ｈｇｆ製剤
US20090202606A1 (en) * 2008-01-25 2009-08-13 Viromed Co., Ltd. Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
CA2926607C (en) 2013-10-22 2018-10-23 Helixmith Co., Ltd Composition for preventing or treating amyotrophic lateral sclerosis using two or more isoforms of hepatocyte growth factor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2777678B2 (ja) 1990-06-11 1998-07-23 敏一 中村 組換ヒト肝実質細胞増殖因子及びその製造方法
JP3283288B2 (ja) 1991-03-08 2002-05-20 電気化学工業株式会社 生理活性ペプチド製剤
DE69230879T2 (de) * 1991-07-26 2000-08-03 Toray Industries, Inc. Verwendung von Hepatocyten-Wachstumsfaktoren zur Herstellung eines Vermehrungssystems für Hematopoietische Stammzellen
JP3394982B2 (ja) * 1991-11-07 2003-04-07 敏一 中村 ガン療法用副作用防止剤
US6498144B1 (en) * 1993-10-18 2002-12-24 North Shore - Long Island Jewish Research Institute Use of scatter factor to enhance angiogenesis
US5837676A (en) * 1993-10-18 1998-11-17 Long Island Jewish Medical Center Use of scatter factor to enhance angiogenesis
JP3818322B2 (ja) * 1994-04-28 2006-09-06 敏一 中村 コラーゲン分解促進剤
JP3977452B2 (ja) * 1995-02-27 2007-09-19 敏一 中村 動脈疾患治療剤
WO1997012629A1 (en) 1995-10-05 1997-04-10 Genentech, Inc. Improved angiogenesis using hepatocyte growth factor
US6391312B1 (en) * 1997-01-23 2002-05-21 Sumitomo Pharmaceuticals Co., Limited Remedies for diabetes
ATE308337T1 (de) * 1997-03-15 2005-11-15 Nakamura Toshikazu Hgf zur behandlung von akutem nierenversagen

Also Published As

Publication number Publication date
EP1103269A1 (de) 2001-05-30
CN1222310C (zh) 2005-10-12
WO2000007615A1 (en) 2000-02-17
AU5065599A (en) 2000-02-28
EP1103269B1 (de) 2011-03-02
CN1315867A (zh) 2001-10-03
DE69943240D1 (de) 2011-04-14
TWI263502B (en) 2006-10-11
US6887477B1 (en) 2005-05-03
EP1103269A4 (de) 2004-11-03
KR20010072207A (ko) 2001-07-31
KR100761675B1 (ko) 2007-10-04
CA2339378A1 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
DE69012591D1 (de) Verwendung von Nikotin zur Herstellung eines Kit zur Behandlung von Krankheitszuständen, die auf eine Nikotinbehandlung ansprechen.
ATE241365T1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
FI922325A0 (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
ATE257378T1 (de) Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen
ES2196027T3 (es) Tratamiento de enfermedades vasculares degenerativas mediante modulacion de la produccion o actividad del oxido nitrico exogeno.
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
KR910005858A (ko) 지방산 요법
UA27102C2 (uk) Склад для стабілізації плазми крові у процесі пастеризації, спосіб пастеризації плазми крові і засіб для терапії препаратом плазми
DE60115432D1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
DE69943240D1 (de) Verwendung von HGF für die Behandlung von ischämischen Erkrankungen der Extremitäten
ATE126061T1 (de) Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum.
ATE185274T1 (de) Therapeutisches mittel gegen drohenden abortus
DE69428995D1 (de) Verfahren zur behandlung von neoplastischen erkrankungen unter verwendung von tiazofurin und ribavirin
ATE243527T1 (de) Arzneistoff zur erleichterung der durch immunsuppressiva verursachten nebenwirkungen
SE7605232L (sv) 1,3-polyhalogen-2-propyletrar
ATE128358T1 (de) Therapeutische mittel für diabetisches gangrän.
DK0402208T3 (da) Sammensætning af vitamin A i fysiologisk dosis og forskellige aktive bestanddele med en terapeutisk aktivitet
DK15088D0 (da) Antibakterielt lyofiliseret praeparat
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ATE335494T1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DE69838399D1 (de) Präparation zur kontinuierlichen intravenösen verabreichung
KR900017599A (ko) 종양 치료용 약학 조성물
NL7513892A (en) Ascorbic acid medicaments for external use - as nasal decongestants and to promote resistance to infection
JPS62242671A (ja) 癌の治療薬

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties